Discriminatory values of the citrulline generation test (CGT) following enteral and intravenous administration of glutamine-alanine in stable ICU patients.

Discriminatory values of the citrulline generation test (CGT) following enteral and intravenous administration of glutamine-alanine in stable ICU patients. - The GLUTSTIM study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON31306

Enrollment

Registered

2007-12-17

Start date

2007-12-01

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stabiele intensive care patienten met allerlei onderliggende aandoeningen malabsorption small bowel (enterocyte) function

Interventions

The citrulline generation test.

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. age between 18-80 2. informed consent 3. fecal production

Exclusion criteria

Exclusion criteria: no signs of malabsorption, liver cirrhosis, steroids (> 10 mg/dag), pregnancy, partenteral nutrition

Design outcomes

Secondary

Measure	Time frame
The determination of the effects of enteral and intravenous glutamine administration on CGT values in these patients. The assessment of differences in plasma citrulline concentrations following venous and arterial blood sampling, respectively	—

Primary

Measure	Time frame
The determination of discriminatory CGT values in stable ICU patients who are able to tolerate enteral nutrition meeting their full protein-energy requirements enteral enery losses (using bomb calorimetry)	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)